Target intelligence / Profile preview

Calreticulin Mutant Protein (CALR mutant)

Target
CALR mutant
Molecular classification
Chaperone, Calcium-binding protein, Oncoprotein
01

Overview

Calreticulin is a multifunctional, calcium-binding chaperone protein primarily located in the endoplasmic reticulum (ER). Mutations in the calreticulin gene (CALR) are most notably associated with certain myeloproliferative neoplasms (MPNs), where they drive disease pathogenesis through altered molecular interactions and signaling pathways. The most common mutations are insertions or deletions (INDELs) in exon 9 of CALR, resulting in a +1 frameshift that alters the C-terminal sequence and the loss of the KDEL ER-retention signal. Mutant calreticulin acquires a novel ability to bind directly to MPL (the thrombopoietin receptor), activating it independently of its ligand, which drives uncontrolled cell proliferation via JAK-STAT signaling.

Other names
Mutant CALRCALR exon 9 mutantCALR frameshift mutant
02

Mechanism of action

Targeting mutant CALR neoepitopes with cancer vaccines; Inhibition of the MPL-JAK2 pathway

03

Biological functions

Altered protein foldingConstitutive MPL activationJAK-STAT signaling activationCell proliferationCalcium homeostasis disruption
04

Disease associations

Myeloproliferative neoplasmsEssential thrombocythemiaPrimary myelofibrosis
05

Safety considerations

Potential for off-target effects on wild-type CALRImmune-related adverse events from neoantigen-based therapiesLimited immunogenicity of mutant CALR neoantigens
06

Biomarkers

CALR mutation statusMutant CALR neoantigens

Beyond the preview

Go deeper on Calreticulin Mutant Protein (CALR mutant).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calreticulin Mutant Protein (CALR mutant).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call